amfAR, The Foundation for AIDS Research

Educational Materials on Hepatitis C Co-infection


TREAT Asia’s educational materials about hepatitis C and HIV co-infection provide easy-to-understand information on hepatitis C and its treatment. They can be used by patients, community members, and healthcare providers to better understand the impact of co-infection and how to manage it.

The materials are available in English, Indonesian, Malay, Mandarin, Thai, and Vietnamese. They include animated videos, flip charts, and booklets featuring a young man named Zaki as he navigates co-infection, plus flyers and treatment planning booklets designed to help patients take and adhere to treatment. These materials are for informational purposes only and should not be used in place of a visit or consultation with a healthcare provider.

For more information about these materials, please contact

Animated videos

Part 1 – Hepatitis C Infection: This video features Zaki explaining hepatitis C infection to his friends and contains basic information on the virus, its modes of transmission, how it can impact health, diagnostic tests, and ways to prevent and treat infection.

Part 2 – Hepatitis C Treatment: This video features Zaki discussing treatment with his healthcare providers and contains basic information on the treatment of hepatitis C for people living with HIV, including descriptions of some of the medicines that can be used, the duration of treatment, possible side effects, and the chances of treatment success.

Flip charts

These flip charts include information about hepatitis C infection and treatment that is similar to the videos.


These individual booklets include information about hepatitis C infection and treatment that is similar to the videos and flip charts.


These flyers explains how to prepare and administer one of the hepatitis C medicines—pegylated interferon (PEG-IFN)—through a sub-cutaneous injection.

Patient treatment plan booklets

These booklets provide diagrams, charts, and calendars to help patients record, monitor, and adhere to their hepatitis C treatment.